2022
Performance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis
Ghaedi B, Cheng W, Ameri S, Abdulkarim K, Costain N, Zia A, Thiruganasambandamoorthy V. Performance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis. Canadian Journal Of Emergency Medicine 2022, 24: 611-621. PMID: 35921048, DOI: 10.1007/s43678-022-00332-x.Peer-Reviewed Original ResearchConceptsNon-viable pregnancyPregnancy viabilityViable pregnancyDiagnostic odds ratioProgesterone levelsFirst trimester pregnant patientsSingle serum progesterone levelSingle serum progesteroneUseful prognostic informationSerum progesterone levelsValue of progesteroneSensitivity 91.3Pregnant patientsSymptomatic patientsCochrane DatabaseFirst trimesterSerum progesteronePrognostic informationOdds ratioPrevalence ratesPatientsPregnancySummary estimatesSpecificity 75Predictive value
2018
Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users
Zigler R, Madden T, Ashby C, Wan L, McNicholas C. Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users. Obstetrics And Gynecology 2018, 132: 888-894. PMID: 30130351, PMCID: PMC6153077, DOI: 10.1097/aog.0000000000002810.Peer-Reviewed Original ResearchConceptsEtonogestrel implant usersUlipristal acetateImplant usersIdentical-appearing placeboPlacebo-controlled trialSerum progesterone levelsUnscheduled bleedingBleeding profilePlacebo groupSecondary outcomesEnrolled participantsEligible participantsSerum progesteroneOvulatory potentialProgesterone levelsOvulation statusPlaceboU.S. FoodDemographic characteristicsWomenBleedingParticipant satisfactionEffect sizeDaysGroup
2016
Does elevated serum progesterone on the day of human chorionic gonadotropin administration decrease live birth rates?
Humm K, Ibrahim Y, Dodge L, Hacker M, Thornton K, Penzias A, Sakkas D. Does elevated serum progesterone on the day of human chorionic gonadotropin administration decrease live birth rates? Journal Of Reproductive Health And Medicine 2016, 2: s15-s18. PMID: 39723888, PMCID: PMC5987253, DOI: 10.1016/j.jrhm.2016.11.008.Peer-Reviewed Original ResearchLive birth rateIn vitro fertilizationElevated serum progesteroneHuman chorionic gonadotropinBirth rateDay of hCG administrationDay of human chorionic gonadotropinDay of human chorionic gonadotropin administrationSerum progesteroneElevated serum progesterone levelsHuman chorionic gonadotropin administrationAssociated with lower pregnancyDecreased live birth rateChorionic gonadotropin administrationSerum progesterone levelsGonadotropin administrationHCG administrationLive birthsLower pregnancyChorionic gonadotropinWhole pregnancyIncreased progesteroneProgesterone levelsPregnancyProgesterone
2013
Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial
Sood R, Warndahl RA, Schroeder DR, Singh RJ, Rhodes DJ, Wahner-Roedler D, Bahn RS, Shuster LT. Bioidentical compounded hormones: A pharmacokinetic evaluation in a randomized clinical trial. Maturitas 2013, 74: 375-382. PMID: 23384975, DOI: 10.1016/j.maturitas.2013.01.010.Peer-Reviewed Original ResearchConceptsClinical trialsEstradiol patchLarge clinical trialsRandomized clinical trialsSerum progesterone levelsStudy medicationOral progesteronePostmenopausal womenHormone therapyEstriol levelsSerum levelsStudy armsEstrogen creamPharmacokinetic trialProgesterone levelsComparable dosesHormonal preparationsPharmacokinetic evaluationPharmacokinetic informationDosesTrialsFurther studiesEstrogenProgesteroneBioidentical
2001
HOXA10 Expression Is Repressed by Progesterone in the Myometrium: Differential Tissue-Specific Regulation of HOX Gene Expression in the Reproductive Tract1
Cermik D, Karaca M, Taylor H. HOXA10 Expression Is Repressed by Progesterone in the Myometrium: Differential Tissue-Specific Regulation of HOX Gene Expression in the Reproductive Tract1. The Journal Of Clinical Endocrinology & Metabolism 2001, 86: 3387-3392. PMID: 11443215, DOI: 10.1210/jcem.86.7.7675.Peer-Reviewed Original ResearchConceptsHox gene expressionHOXA10 expressionHox genesDifferential tissue-specific regulationHigh serum progesterone levelsGene expressionPrimary myometrial cell culturesSerum progesterone levelsDevelopmental regulatory genesAdult human endometriumDifferential HOX gene expressionSteroid receptor coactivatorTissue-specific regulationTissue-specific responsesMyometrial cell culturesEndometrial developmentProgesterone receptorMenstrual cycleHuman endometriumMulticellular organismsNonpregnant uterusProgesterone levelsSex steroidsMidsecretory phaseMyometrium
1997
Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells
Arici A, Oral E, Bukulmez O, Buradagunta S, Bahtiyar O, Jones E. Monocyte chemotactic protein-1 expression in human preovulatory follicles and ovarian cells. Journal Of Reproductive Immunology 1997, 32: 201-219. PMID: 9080384, DOI: 10.1016/s0165-0378(97)82476-x.Peer-Reviewed Original ResearchConceptsMonocyte chemotactic protein-1MCP-1 levelsFollicular fluidHCG administrationPreovulatory folliclesPg/Granulosa-lutein cell culturesSerum MCP-1 levelsMacrophage migrationMCP-1 mRNA expressionChemotactic protein-1 expressionAdministration of hCGHuman preovulatory folliclesSerum progesterone levelsChemotactic protein-1Human ovarian folliclesFollicular fluid samplesHuman follicular fluidGranulosa-lutein cellsLH/hCGInterleukin-1 alphaMonocytes/macrophagesProtein-1 expressionMCP-1 mRNAPg/mL
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply